Generic Drug Pricing The Scandal Of Generic Drug Pricing: Drug Regulation Policies Need Review
BMJ-BRITISH MEDICAL JOURNAL(2017)
摘要
We welcome the news that the Competitions and Market Authority is now taking drug companies such as GlaxoSmithKline, Pfizer, and Flynn Pharma to task for overcharging the NHS for generic drugs.1 In December, the authority announced that it was investigating Actavis for inflating the price of hydrocortisone, a WHO essential medicine used to treat adrenal insufficiency.2The price of hydrocortisone has risen by …
更多查看译文
关键词
generic drug pricing,drug regulation policies,scandal
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络